You are here: Industry Insights > CDMO

News List

Genezen Laboratories Receives Growth Equity Investment contractpharma
January 06, 2021
Genezen Laboratories Inc. has received a majority investment from Ampersand Capital Partners, a private equity firm specializing in growth equity investments in the healthcare sector.
CHA Biotech Launches Global CDMO Biz contractpharma
December 17, 2020
South Korea-based CHA Biotech has launched Matica Biotechnology, a contract development and manufacturing organization (CDMO) specializing in the clinical and commercial production of cell and gene therapies.
CDMO Cognate BioServices Teams Up with L7 Informatics contractpharma
December 17, 2020
L7 Informatics has partnered with Cognate BioServices, a commercial-ready contract development and manufacturing organization (CDMO) in the cell and gene therapy industry, to deploy L7|ESP (Enterprise Science Platform) and implement an integrated ...
Inhalation CDMO Vectura Expands HPAPI Capabilities contractpharma
December 15, 2020
Vectura Group, an inhalation contract and development manufacturing organization (CDMO), has expanded its capabilities to handle and develop highly potent active pharmaceutical ingredients (HPAPIs) at its facility in Chippenham, UK.
EQT makes $2.8 bn bid for Recipharm expresspharma
December 15, 2020
EQT said it was bidding 220 crowns per Recipharm share, a 22.9 per cent premium to Recipharm’s closing price.
Ascentage Selects PharmaBlock as Preferred Provider contractpharma
December 14, 2020
PharmaBlock will support Ascentage in accelerating its drug development pipeline with R&D, manufacturing capacity, and technological solutions.
atbtherapeutics Enters Manufacturing Agreement with iBio CDMO contractpharma
December 10, 2020
atbtherapeutics, a biopharmaceutical company building an oncology pipeline using its antibody–toxin-bioengineered “atbody,” has entered a long-term manufacturing agreement with iBio CDMO, a global leader in plant-based biologics manufacturing located ...
iBio to Provide CDMO Services for ATB Therapeutics contractpharma
December 04, 2020
iBio will produce ATB’s bioengineered antibody-toxin fusion proteins.
Sterling Makes Strategic Investment in ADC Bio contractpharma
December 03, 2020
Sterling Pharma Solutions, a global CDMO, has entered a new strategic partnership with ADC Biotechnology, a UK company specializing in antibody drug conjugates.
CDMO Stelis Continues Expansion contractpharma
December 02, 2020
Contract development and manufacturing organization (CDMO), Stelis BioSource, a division of Stelis Biopharma Pvt. Ltd., has started the next phase of its continued investment program after having already invested well over $100 million into its ...

Previous page 1 2 3 4 5 6 7 8 9 10 ... 29 30 Next page